Papers

1

Total Citations

11

H-Index

1

About

Dr. Anjali Joshi is a leading figure in the automation of biochemical assays, with a focused expertise in high-throughput analytics for vaccine development. Her most impactful work centers on democratizing laboratory automation, as exemplified by her highly cited 2024 paper on creating an open-sourced, inexpensive robotic liquid handler. This contribution directly addresses a critical bottleneck in pharmaceutical research, making high-throughput screening accessible beyond well-funded corporate labs. Within her role in Vaccines Analytical Research and Development (V-AR&D), Dr. Joshi has been instrumental in advancing the High Throughput Analytics (HTA) group, streamlining assay development for drug discovery. Her work has already garnered 11 citations, reflecting its immediate relevance to researchers seeking cost-effective automation solutions. By bridging the gap between expensive commercial systems and practical lab needs, Dr. Joshi is not only accelerating vaccine research but also empowering smaller labs to participate in cutting-edge biochemical discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Automation of biochemical assays using an open-sourced, inexpensive robotic liquid handler
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago